Intravitreal triamcinolone acetonide for florid proliferative diabetic retinopathy

Graefes Arch Clin Exp Ophthalmol. 2004 Dec;242(12):1024-7. doi: 10.1007/s00417-004-0911-1. Epub 2004 Apr 3.


Background: The spectrum of ocular indications in which intravitreal injections of triamcinolone acetonide may be therapeutically useful has recently been expanding.

Methods: Prospective clinical interventional case study in a young adult male with florid proliferative diabetic retinopathy (FPDR).

Results: A greater reduction of retinal thickening and fluorescein leakage from retinal new vessels was observed in the right eye after intravitreal injection of triamcinolone followed by scatter panretinal photocoagulation (PKP) than in the left eye treated only by laser.

Conclusion: Intravitreal injection of triamcinolone acetonide may be a useful adjunct to scatter panretinal photocoagulation for FPDR.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Blood-Retinal Barrier
  • Capillary Permeability
  • Diabetic Retinopathy / drug therapy*
  • Diabetic Retinopathy / surgery
  • Fluorescein Angiography
  • Glucocorticoids / therapeutic use*
  • Humans
  • Injections
  • Laser Coagulation
  • Male
  • Triamcinolone Acetonide / therapeutic use*
  • Visual Acuity
  • Vitreous Body


  • Glucocorticoids
  • Triamcinolone Acetonide